Unfair Market Cap of $55 million Please tell us you're kidding!
This is purely about arithmetic and economics (economy of scale). First of all it doesn't appear there is a country in Europe, Africa, North America or South America that is currently carrying out mass use of rapid tests. I described in posts earlier today and in the past as to why this isn't happening.
Even with almost 200 million outstanding shares and a sp of $1.00 would be an under evaluation of a company (Thrm) that could provide millions of rapid covid tests (CoviSafe). Is it a done deal, no. We won't know that until the next NR. Is it a speculative stock, yes. But every NR since July has been a necessary piece of a very large and lucrative puzzle for both Thrm and its investors.
No reading between the lines, no pumping, no bashing .....just FACT!
GLTA!